Parkinson's
-
Berwyn-Based Annovis Bio Postpones Release of Data for Its Experimental Parkinson’s Treatment
Berwyn-based Annovis Bio is delaying the release of the late-stage study results of its experimental Parkinson’s disease treatment, writes John George for the Philadelphia Business…
-
Forbes: This Berwyn Stock Shows Major Potential in an Otherwise Weak Biotech Market
While biotech is a tough line of work that has a historically high percentage of companies whose stock trades at or below their cash value,…
-
Berwyn Biotech Company Raises Millions to Advance Parkinson’s, Alzheimer’s Treatment
Annovis Bio, a Berwyn-based biotech company, has managed to raise $8.7 million to advance its experimental treatment for Parkinson’s and Alzheimer’s diseases, writes John George…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
